Genentech taps small Boston pharma for $20M deal

Pieris Pharmaceuticals, a small biotech behind a suite of engineered proteins it calls anticalins, has signed a major research and development deal with Genentech for respiratory and ophthalmology treatments. Read More

Read More

Flagship-founded agtech startup plans to commercialize within a year

When Invaio Sciences Inc. launched publicly barely a year ago, fresh from the halls of Cambridge venture creation firm Flagship Pioneering, it had lofty goals: to manage insect populations while also reducing the use of pesticides. Now, with promising results from partnerships in Italy and Brazil, Invaio is planning to commercialize its technologies within the…

Read More